About
Meridigen develops stem cell-based therapeutic drugs focusing on mesenchymal stem cells and offers contract research and manufacturing services for biomedical research.
Explore Meridigen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.